OA07002A - Dérivé de la pyrrolidine, sa préparation et ses utilisations thérapeutiques pour le traitement de l'insuffisance cérébrale. - Google Patents

Dérivé de la pyrrolidine, sa préparation et ses utilisations thérapeutiques pour le traitement de l'insuffisance cérébrale.

Info

Publication number
OA07002A
OA07002A OA57598A OA57598A OA07002A OA 07002 A OA07002 A OA 07002A OA 57598 A OA57598 A OA 57598A OA 57598 A OA57598 A OA 57598A OA 07002 A OA07002 A OA 07002A
Authority
OA
OAPI
Prior art keywords
preparation
treatment
therapeutic uses
pyrrolidine derivative
cerebral insufficiency
Prior art date
Application number
OA57598A
Other languages
English (en)
French (fr)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of OA07002A publication Critical patent/OA07002A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
OA57598A 1981-02-05 1982-01-28 Dérivé de la pyrrolidine, sa préparation et ses utilisations thérapeutiques pour le traitement de l'insuffisance cérébrale. OA07002A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH77081A CH646149A5 (de) 1981-02-05 1981-02-05 Pyrrolidin-derivat.

Publications (1)

Publication Number Publication Date
OA07002A true OA07002A (fr) 1983-08-31

Family

ID=4194769

Family Applications (1)

Application Number Title Priority Date Filing Date
OA57598A OA07002A (fr) 1981-02-05 1982-01-28 Dérivé de la pyrrolidine, sa préparation et ses utilisations thérapeutiques pour le traitement de l'insuffisance cérébrale.

Country Status (40)

Country Link
US (1) US4452807A (it)
EP (1) EP0057846B1 (it)
JP (1) JPS57146753A (it)
KR (1) KR830009023A (it)
AR (1) AR231127A1 (it)
AT (2) ATE13668T1 (it)
AU (1) AU552063B2 (it)
BG (1) BG36932A3 (it)
BR (1) BR8200615A (it)
CA (1) CA1158250A (it)
CH (1) CH646149A5 (it)
CS (1) CS227035B2 (it)
DD (1) DD202539A5 (it)
DE (2) DE3263960D1 (it)
DK (1) DK20682A (it)
ES (1) ES509312A0 (it)
FI (1) FI820192A7 (it)
FR (1) FR2499075A1 (it)
GB (1) GB2092584B (it)
GR (1) GR76052B (it)
HU (1) HU184988B (it)
IE (1) IE52439B1 (it)
IL (1) IL64896A (it)
IS (1) IS2700A7 (it)
IT (1) IT1153402B (it)
LU (1) LU83923A1 (it)
MC (1) MC1440A1 (it)
NL (1) NL8200337A (it)
NO (1) NO820346L (it)
NZ (1) NZ199624A (it)
OA (1) OA07002A (it)
PH (1) PH18267A (it)
PL (1) PL135221B1 (it)
PT (1) PT74387B (it)
RO (1) RO83099B (it)
SE (1) SE8200647L (it)
SU (1) SU1143315A3 (it)
YU (1) YU23982A (it)
ZA (1) ZA82608B (it)
ZW (1) ZW1982A1 (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
FR2551751B1 (fr) * 1983-09-12 1986-04-25 Serobiologiques Lab Sa Nouveau procede de preparation d'un derive pyroglutamique, nouveaux derives pyroglutamiques, nouveaux intermediaires de synthese de preparation de ceux-ci et utilisation ou application des derives pyroglutamiques comme agents antibacteriens ou antifongiques
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3632589A1 (de) * 1985-10-18 1987-04-23 Bayer Ag Verfahren zur herstellung von (gamma)-butyrolactamen
DE3537075A1 (de) * 1985-10-18 1987-04-23 Bayer Ag Verfahren zur herstellung von clausenamid
US4677114A (en) * 1985-11-22 1987-06-30 Warner-Lambert Company Pyrrolidone-2 derivatives and pharmaceutical compositions thereof
IT1215587B (it) * 1987-06-26 1990-02-14 Roussel Maestretti Spa Derivati della 1-benzoil2-oxo 5-alcossi pirrolidina, loro procedimento di preparazione e loro impiego come sostanza medicinale.
JPH0720930B2 (ja) * 1988-07-09 1995-03-08 明治製菓株式会社 ピロリジノン化合物及び脳機能障害改善剤
US5049577A (en) * 1990-01-29 1991-09-17 E. R. Squibb & Sons, Inc. 2-pyrrolidone substituted dihydroxy alkanoic, alkenoic and alkynoic acids, compositions and HMG-CoA reductase inhibition therewith
US5049578A (en) * 1990-03-09 1991-09-17 E. R. Squibb & Sons, Inc. 1-aroyl or 1-acyl-2-2pyrrolidinyl-3,5-dihydroxy alkanoic and alkenoic acids, salts, esters and lactones
DE69331761T2 (de) * 1992-07-24 2002-09-12 The Regents Of The University Of California, Oakland Arzneimittel, die den durch ampa rezeptoren vermittelten synaptischen respons erhöhen
US5852008A (en) * 1995-01-24 1998-12-22 The Regents Of The University Of California Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES433723A1 (es) * 1975-01-10 1976-11-16 Lafarquim S A Lab Procedimiento de obtencion de un derivado de 2-pirrolidi- nona.
IT1045043B (it) * 1975-08-13 1980-04-21 Isf Spa Derivati pirrolidinici
CU21107A3 (es) * 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives
CA1115212A (en) * 1978-02-10 1981-12-29 Emilio Kyburz Pyrrolidine derivatives
CA1124247A (en) * 1979-08-09 1982-05-25 Hoffmann-La Roche Limited Pyrrolidine derivatives

Also Published As

Publication number Publication date
ES8304545A1 (es) 1983-03-16
HU184988B (en) 1984-11-28
PL135221B1 (en) 1985-10-31
FI820192L (fi) 1982-08-06
CA1158250A (en) 1983-12-06
EP0057846A1 (de) 1982-08-18
DE3263960D1 (en) 1985-07-11
MC1440A1 (fr) 1982-12-06
JPS57146753A (en) 1982-09-10
AU8010482A (en) 1982-08-12
LU83923A1 (de) 1983-09-02
AT377982B (de) 1985-05-28
ES509312A0 (es) 1983-03-16
ATA41882A (de) 1984-10-15
NO820346L (no) 1982-08-06
DE3202281A1 (de) 1982-09-16
CS227035B2 (en) 1984-04-16
ZW1982A1 (en) 1982-09-01
BR8200615A (pt) 1982-12-14
BG36932A3 (bg) 1985-02-15
JPH0354097B2 (it) 1991-08-19
RO83099B (ro) 1984-02-28
AR231127A1 (es) 1984-09-28
FR2499075A1 (fr) 1982-08-06
FI820192A7 (fi) 1982-08-06
GB2092584B (en) 1984-08-01
PL234962A1 (it) 1982-09-27
AU552063B2 (en) 1986-05-22
ZA82608B (en) 1982-12-29
SU1143315A3 (ru) 1985-02-28
PT74387A (en) 1982-03-01
IS2700A7 (is) 1982-08-06
IL64896A0 (en) 1982-03-31
GR76052B (it) 1984-08-03
IT8219115A0 (it) 1982-01-14
IT1153402B (it) 1987-01-14
NZ199624A (en) 1984-12-14
DK20682A (da) 1982-08-06
GB2092584A (en) 1982-08-18
RO83099A (ro) 1984-02-21
CH646149A5 (de) 1984-11-15
YU23982A (en) 1985-03-20
US4452807A (en) 1984-06-05
IE52439B1 (en) 1987-10-28
PH18267A (en) 1985-05-14
DD202539A5 (de) 1983-09-21
IL64896A (en) 1985-07-31
ATE13668T1 (de) 1985-06-15
KR830009023A (ko) 1983-12-17
SE8200647L (sv) 1982-08-06
IE820249L (en) 1982-08-05
NL8200337A (nl) 1982-09-01
PT74387B (en) 1984-10-22
EP0057846B1 (de) 1985-06-05

Similar Documents

Publication Publication Date Title
BE889930A (fr) Derives de l'indole, leur preparation et leurs utilisations therapeutiques
FR2572651B1 (fr) Appareil perfectionne pour le traitement de l'oedeme des membres par pression
BE890648A (fr) Compositions pour le traitement de l'acne
OA08617A (fr) Inhibiteurs de métalloendopeptidase neutre dans le traitement de l'hypertention.
BE890024A (fr) Derives tricycliques de l'imidazole, leur preparation et leurs utilisations therapeutiques
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
OA06599A (fr) Procédé de préparation d'un agent pour le traitement de théilérioses.
BE889929A (fr) Derives de l'indole, leur preparation et leurs utilisations therapeutiques
FR2556348B1 (fr) Retinoides, leur preparation et leurs utilisations therapeutiques, notamment pour le traitement des neoplasies, de l'acne et du psoriasis
FR2554814B1 (fr) Oxazolidines, procede pour leur preparation et leurs utilisations therapeutiques, notamment dans le traitement de l'obesite et du diabete
EP0270690A4 (en) MEDICINES FOR THE TREATMENT AND PROPHYLAXIS OF LIVER AND KIDNEY DISEASES.
BE892882A (fr) Procede pour la prophylaxie et le traitement de l'insuffisance cerebrale
FR2636985B1 (fr) Composition assouplissante et procede pour le traitement de textiles
FR2717080B1 (fr) Utilisation de l'éliprodil et de ses énantiomères pour la préparation de médicaments utiles dans le traitement des neuropathies périphériques et des maladies neurodégénératives centrales.
BE892602A (fr) Esters de mercaptoacyl-carnitines, procede pour leur preparation et leurs utilisations therapeutiques
FR2558372B1 (fr) Composition medicamenteuse pour le traitement de l'acne
FR2658419B1 (fr) Medicament pour le traitement de la dermatite.
EP0667157A4 (en) AGENT FOR TREATING CYCLING COMPLAINTS.
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
FR2544614B1 (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension
MA19564A1 (fr) Derives de la pyrrolidine, sa preparation et ses utilisations therapeutiques pour le traitement de l'insuffisance cerebrale
FR2503150B1 (fr) Mercaptoacyl-carnitines, procede pour leur preparation et leurs utilisations therapeutiques dans le traitement des intoxications et des brulures et en tant qu'agents mucolytiques
RO76126A2 (ro) Procedeu pentru prepararea acizilor antrachinon 2,6-si-2,7-disulfonici
FR2296415A1 (fr) Preparations pharmaceutiques pour le traitement des troubles de la circulation
OA07728A (fr) Dérivés de l'acide bicyclo (3.2.1.) octane carboxylique, leur procédé de préparation et leur application thérapeutique.